StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Audentes Therapeutics (BOLD) PT Lowered to $41 at Piper Jaffray
November 7, 2018 4:34 AM
Piper Jaffray analyst Christopher Raymond ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change